Matteucinol combined with temozolomide inhibits glioblastoma proliferation, invasion, and progression: an in vitro, in silico, and in vivo study

Glioblastoma is the most prevalent and malignant brain tumor identified in adults. Surgical resection followed by radiotherapy and chemotherapy, mainly with temozolomide (TMZ), is the chosen treatment for this type of tumor. However, the average survival of patients is around 15 months. Novel approa...

Descripción completa

Detalles Bibliográficos
Autores principales: Netto, J.B., Melo, E.S.A., Oliveira, A.G.S., Sousa, L.R., Santiago, L.R., Santos, D.M., Chagas, R.C.R., Gonçalves, A.S., Thomé, R.G., Santos, H.B., Reis, R.M., Ribeiro, R.I.M.A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Associação Brasileira de Divulgação Científica 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9394692/
https://www.ncbi.nlm.nih.gov/pubmed/36000612
http://dx.doi.org/10.1590/1414-431X2022e12076

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9394692/
https://www.ncbi.nlm.nih.gov/pubmed/36000612
http://dx.doi.org/10.1590/1414-431X2022e12076

Ejemplares similares